Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 28, 2012; 18(48): 7149-7157
Published online Dec 28, 2012. doi: 10.3748/wjg.v18.i48.7149
Published online Dec 28, 2012. doi: 10.3748/wjg.v18.i48.7149
AASLD 2009[27] | EASL 2012[101] | |
LAM-resistance | Add ADV or TDF | Switch to TDF or add ADV |
In patients with no prior exposure to other NA: Add LAM or ETV | In patients with no prior exposure to other NA: Switch to ETV or TDF | |
ADV-resistance | In patients with prior LAM resistance: Switch to TDF plus LAM or ETV | In patients with prior LAM resistance: Switch to TDF and another NA |
ETV-resistance | Switch to TDF | Switch to or add TDF |
TDF-resistance | -- | In patients with no prior exposure to LAM: Switch to ETV |
In patients with prior LAM resistance: Add ETV |
- Citation: Song ZL, Cui YJ, Zheng WP, Teng DH, Zheng H. Diagnostic and therapeutic progress of multi-drug resistance with anti-HBV nucleos(t)ide analogues. World J Gastroenterol 2012; 18(48): 7149-7157
- URL: https://www.wjgnet.com/1007-9327/full/v18/i48/7149.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i48.7149